Personalized regenerative medicine, built on science.
LYRACELL is a regenerative medicine and cell therapy clinic based in Buenos Aires. It brings together more than 20 years of research linked to the Moviglia Method, an interdisciplinary medical team and LYRACELL Lab, its in-house laboratory, to design personalized treatments based on each patient’s diagnosis, the tissues that need treatment and their goals.
20+ years of researchMoviglia MethodIn-house laboratoryBuenos Aires

A scientific journey that keeps evolving.
Dr. Gustavo Moviglia, LYRACELL’s scientific lead, began researching the different functions of the immune system in the 1970s. He spent his early years as a researcher at CONICET (National Scientific and Technical Research Council), Argentina’s main public body dedicated to promoting science and technology. There he deepened his training in cell culture and began studying the interaction between different cell populations and the immune system.
In the 1990s he pioneered the development of anti-tumor vaccines and immunomodulatory treatments for autoimmune diseases. Studying these conditions allowed him to gain deeper insight into the role the immune system plays in the body’s natural repair processes.

This research gave rise to what we know today as the Moviglia Method: a strategy aimed at supporting the repair of damaged tissues through biological mechanisms present in the body itself. Over ten years of basic and, later, clinical research, between 1996 and 2006, Dr. Moviglia developed an in vitro technique in which, by co-culturing the patient’s stem cells with previously selected and activated immune system cells, the stem cells are induced to pre-differentiate into cells of the tissue to be repaired. This development, initially applied to the treatment of diseases of the brain and spinal cord, was later extended to other tissues, such as the joints, spine, muscle, heart and lungs, among others.
Over more than two decades, the research moved into clinical practice and a team was consolidated that integrates basic science, laboratory techniques for developing different cell therapies, and patient care. Today, under the direction of Dr. Teresita Moviglia, LYRACELL continues that path of research and scientific development, with a focus on bringing those advances into clinical practice. It builds on a principle that has guided the development of the Moviglia Method: working with the biological mechanisms and resources present in the body and integrating them with new technologies to support repair processes.
With a personalized strategy, from start to finish.
Each treatment brings together four dimensions:

Medical evaluation
To understand each patient’s current condition, history and needs.

Cell therapy with the Moviglia Method
It is proposed when the conditions are right and is defined according to the characteristics of each case.

LYRACELL Lab
The space where cells are selected, expanded, differentiated and stored under controlled conditions, with quality protocols and traceability at every stage.

Clinical follow-up and long-term monitoring
With objective measures that make it possible to evaluate results and define future strategies according to each patient’s needs.
This integration means the treatment proposal is not limited to a single application. Each stage is planned, discussed with the patient and coordinated between the medical team and LYRACELL Lab.
The diagnosis guides the treatment. Each patient’s story helps us understand their needs and define the goals.
Even when two people share a diagnosis, they may have different degrees of involvement, histories, needs and expectations.
That is why the process begins with a review of the medical history and available studies. When necessary, the team requests additional studies to better understand the condition and the affected tissues. If cell therapy may be an option, the team prepares a personalized proposal that explains the goals, the stages and the planned follow-up.
The patient takes an active part in that decision and knows the plan before starting.

Science, clinical experience and interdisciplinary work.
Dr. Gustavo Moviglia led the scientific development that gave rise to the Moviglia Method. Dr. Teresita Moviglia continued and expanded that legacy from the clinical and institutional leadership, building a team focused on research, care and patient follow-up.
Depending on the reason for consultation, professionals from different specialties work together in an interdisciplinary way to bring the perspectives each case needs.

Medical Direction
Dr. Teresita Moviglia, MD
Medical Direction · President of ACIDTA
Clinical immunologist. She leads the scientific backing of the Moviglia Method.

Technical Direction
Dr. Gustavo A. Moviglia, MD, PhD
Technical Direction · Research and Development Advisor
He leads the laboratory’s technical operations and the research lines of the Moviglia Method.
More than 20 years of research and publications in journals such as Science Advances and Journal of Neurorestoratology support the development of the Moviglia Method.
In a field that keeps evolving, evidence makes it possible to review protocols, ask new questions and guide each indication responsibly. It is not a promise of results: the response may vary depending on each patient’s condition and characteristics.
LYRACELL works together with ACIDTA on the development of research protocols that explore the potential of cell therapy and its possible therapeutic applications.

Cell therapy for osteoarthritis
A study published in the scientific journal Science Advances proposes a new mechanism to address knee osteoarthritis…

Stem cells for facial rejuvenation
Over time, facial skin loses collagen, hyaluronic acid and elastin, and its ability to regenerate…

Tendinitis: causes and treatment with cell therapy
Tendinitis is one of the most common reasons for orthopedic consultation: it occurs when a tendon becomes inflamed and causes pain…
Everything you need to know about LYRACELL
LYRACELL is a regenerative medicine and cell therapy clinic in Buenos Aires. It integrates the Moviglia Method, an interdisciplinary medical team, an in-house laboratory and clinical follow-up.
The Moviglia Method is the scientific and clinical foundation on which the cell treatments that LYRACELL applies in regenerative medicine are developed.
No. Each indication is defined after evaluating the person’s diagnosis, the tissues involved, their history and their goals.
The base treatment is autologous: the mesenchymal stem cells come from the patient and are usually obtained from adipose tissue through a mini-liposuction. They can also be obtained from bone marrow or, if the patient banked them at birth, from the umbilical cord or placenta. The immune system cells are obtained from a blood sample from the patient. In certain cases, depending on the medical indication, immune system cells from a selected donor may be used.
The clinic is located in Buenos Aires, Argentina, and receives inquiries from local and international patients.
The first step is understanding your case.
Share your medical history and test results so the medical team can carry out an initial evaluation.